Apixaban versus Warfarin in Patients with Chronic Kidney Disease; A Systematic Review and Meta-analysis-Reference-Cited by-同舟云学术

Apixaban versus Warfarin in Patients with Chronic Kidney Disease; A Systematic Review and Meta-analysis

Published:2021-06-30 Issue:2 Volume:31 Page:87-95
ISSN:1226-6051
Container-title:Korean Journal of Clinical Pharmacy
language:en
Short-container-title:Korean J Clin Pharm

Author:

Nam Jae Hyun¹²,Kim Chae Young¹,Lee Yoo Kyung¹,Jung Da Woom¹,Gwak Hye Young²,Chung Jee Eun¹

Affiliation:

1. College of Pharmacy and Institute of Pharmaceutical Science and Technology, Hanyang University, 55 Hanyangdaehak-ro, Sangnok-gu, Ansan, Gyeonggido 15588, Republic of Korea

2. Department of Pharmacy, Hanyang University Hospital, 222 Wangsimni-ro, Seongdong-gu, Seoul 04763, Republic of Korea

Funder

National Research Foundation of Korea

Hanyang University

Publisher

The Korean College of Clinical Pharmacy

Subject

General Medicine

Link

http://pdf.medrang.co.kr/KJCP/2021/031/KJCP031-02-01.pdf

Reference37 articles.

1. Correction to: 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society

2. Efficacy and safety of rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome: Rationale and design of the Trial on Rivaroxaban in AntiPhospholipid Syndrome (TRAPS) trial

3. Use of the direct oral anticoagulants in obese patients: guidance from the SSC of the ISTH

4. Glomerular hemodynamics in severe obesity

5. Tobenkin A, Mohamoud M, Munoz M, et al. Direct oral anticoagulants and menorrhagia in premenopausal women: data from the food and drug administration adverse event reporting system and US drug utilization. Haemophilia. 2017;23(Suppl 3):43.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimal Target Low-density Lipoprotein Level for Reducing the Risk of Atherosclerotic Cardiovascular Diseases: A Systematic Review and Meta-analysis;Korean Journal of Clinical Pharmacy;2023-12-31